Navigation Links
Orexigen® Therapeutics Reports Second Quarter Ended June 30, 2011 Financial Results
Date:8/8/2011

continuing the dispute resolution process because we strongly believe that there is a patient population for Contrave that has a risk:benefit profile that justifies approval without results from a cardiovascular outcomes trial," stated Mike Narachi, Orexigen President and CEO.  "Importantly, we have prioritized the pursuit of additional assets and are optimistic in these business development efforts."  

About Orexigen TherapeuticsWe are a biopharmaceutical company focused on expanding our pipeline of product candidates through one or more in-license, asset acquisitions or merger transactions where we can leverage our management team, cash and other resources.  Our strategy stems from feedback received from the U.S. Food and Drug Administration, or FDA, concerning substantial additional development requirements for our lead product candidate, Contrave.  Contrave has completed Phase III clinical trials, and our other product candidate, Empatic™, has completed Phase II clinical trials.  Each of the components of our product candidates has already received regulatory approval and has been commercialized previously.  We are appealing the FDA's additional development requirements for Contrave through the formal dispute resolution process. Further information about the Company can be found at www.orexigen.com.

Forward-Looking Statements  Orexigen cautions you that statements included in this press release that are not a description of historical facts are forward-looking statements.  Words such as "believes," "anticipates," "plans," "expects," "indicates," "will," "intends," "potential," "suggests," "assuming," "designed" and similar expressions are intended to identify forward-looking statements.  These statements are based on the Company's current beliefs and expectations.  These forward-looking statements include statements regarding substantially lower c
'/>"/>

SOURCE Orexigen Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Orexigen® Therapeutics Announces FDA Acceptance of Contrave® New Drug Application for the Treatment of Obesity
2. Orexigen® Therapeutics Schedules August 5, 2010 Webcast Discussion of Financial Results for the Second Quarter Ended June 30, 2010
3. Orexigen® Therapeutics Announces Publication of COR-I Phase 3 Study of Contrave in Lancet
4. Orexigen® Therapeutics COR-BMOD Study Published in the Journal Obesity
5. Orexigen® Therapeutics and Takeda Enter Into Partnership to Commercialize Contrave® in North America
6. Orexigen® Therapeutics to Speak at Rodman & Renshaw Annual Global Investment Conference
7. Orexigen® Therapeutics to Speak at Fifth Annual JMP Securities Healthcare Conference
8. Orexigen® Therapeutics Reports Third Quarter 2010 Financial Results
9. Orexigen® Therapeutics Investigational Drug Contrave® Receives Positive Recommendation from FDA Advisory Committee for Treatment of Obesity
10. Orexigen® Therapeutics, Inc. Announces Upcoming Departure of Chief Financial Officer
11. Orexigen® Therapeutics Schedules March 10, 2011 Webcast Discussion of Financial Results for the Fourth Quarter and Year Ended December 31, 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... DUBLIN , July 11, 2014 ... "Global Hypodermic Needles Market 2014-2018" report to ... A hypodermic needle is a hollow needle ... the body or or to extract fluids from it. ... liquids or to inject substances that cannot be ingested. ...
(Date:7/11/2014)...  Australian drug delivery company, Phosphagenics Limited (ASX: POH; ... million via a placement of A$16.3 million to institutional ... Asia and Australia ... plan (SPP) to be offered to existing shareholders.  The ... tranches. "This capital raising positions us strongly ...
(Date:7/11/2014)... 11, 2014 According to a ... Devices Market (Endoscopes, Endoscopic Operative Devices, and Visualization Systems) ... Forecast, 2013-2019" the global endoscopy devices market was valued ... to grow at a CAGR of 6.8% from 2013 ... 36.9 billion in 2019. Browse the full ...
Breaking Medicine Technology:Global Hypodermic Needles Market 2014-2018: Key Vendors are Becton, Dickinson and Co, Covidien, Retractable Technologies and Terumo Corp. 2Global Hypodermic Needles Market 2014-2018: Key Vendors are Becton, Dickinson and Co, Covidien, Retractable Technologies and Terumo Corp. 3Phosphagenics' A$19.3 million Capital Raising 2Phosphagenics' A$19.3 million Capital Raising 3Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 2Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 3Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 4Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 5Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 6
... 2010 /PRNewswire-- Sangart, Inc., a global biopharmaceutical ... to enhance the perfusion and oxygenation of ischemic ... gas delivery, today announced that its investigational biopharmaceutical ... by the U.S. Food and Drug Administration (FDA) ...
... A new electronic health record (EHR) safety reporting ... not-for-profit organization composed of medical society and professional liability ... Network. EHRevent.org establishes a national system where ... related to the implementation and use of EHRs. ...
Cached Medicine Technology:Sangart, Inc. Receives U.S. Orphan Drug Designation for use of MP4CO in Patients with Sickle Cell Disease 2Sangart, Inc. Receives U.S. Orphan Drug Designation for use of MP4CO in Patients with Sickle Cell Disease 3New National Electronic Health Record Safety System Launched 2New National Electronic Health Record Safety System Launched 3New National Electronic Health Record Safety System Launched 4New National Electronic Health Record Safety System Launched 5New National Electronic Health Record Safety System Launched 6
(Date:7/12/2014)... July 12, 2014 The report, "Phthalic ... Resins) Market by Application & Geography – Trends & ... with analysis and forecasting of market volume and value. ... the derivatives separately. The market of phthalic anhydride is ... 2013 to $8,415.89 million by 2018, with a CAGR ...
(Date:7/12/2014)... 12, 2014 The ... Vascular Devices Market by Angioplasty Balloon ... (IVUS, OCT), IVC Filter (Retrievable), Endovascular ... analyzes and studies the major market ... U.S. and Canada. , Browse 108 ...
(Date:7/12/2014)... 12, 2014 Demand Response Management Systems ... benefits in reducing the imbalance between energy supply and ... have been rolled out (due to increasing pressure on ... This helps in controlling residential appliances and thermostats for ... the North American region, and with government mandates and ...
(Date:7/12/2014)... July 12, 2014 The fastest-growing mobile ... test and measurement of LTE networks continues to grow ... for smart devices have increased mobile data traffic, which ... Measurement (CT&M) market. Communications Test and Measurement equipment comply ... , The Communications Test and Measurement Market is estimated ...
(Date:7/12/2014)... Casinos in Australia have ... from international and online casinos. Revenue is estimated to ... years through 2014-15. Greater per capita gambling expenditure has ... Rises in discretionary income levels have also assisted revenue ... items such as casino gambling services. Revenue is estimated ...
Breaking Medicine News(10 mins):Health News:Phthalic Anhydride Market Projected to Reach $8.42 Billion by 2018 – Report by MarketsandMarkets 2Health News:Phthalic Anhydride Market Projected to Reach $8.42 Billion by 2018 – Report by MarketsandMarkets 3Health News:Phthalic Anhydride Market Projected to Reach $8.42 Billion by 2018 – Report by MarketsandMarkets 4Health News:North American Interventional Cardiology & Peripheral Vascular Devices Market - New Report by MarketsandMarkets 2Health News:North American Interventional Cardiology & Peripheral Vascular Devices Market - New Report by MarketsandMarkets 3Health News:North American Interventional Cardiology & Peripheral Vascular Devices Market - New Report by MarketsandMarkets 4Health News:North American Interventional Cardiology & Peripheral Vascular Devices Market - New Report by MarketsandMarkets 5Health News:North America Demand Response Management System Worth $12,522.4 Million by 2019 - New Report by MicroMarket Monitor 2Health News:North America Demand Response Management System Worth $12,522.4 Million by 2019 - New Report by MicroMarket Monitor 3Health News:North America Demand Response Management System Worth $12,522.4 Million by 2019 - New Report by MicroMarket Monitor 4Health News:North America Communication Test and Measurement (CT&M) Market Worth $1.9 Billion by 2018 - New Report by MicroMarket Monitor 2Health News:North America Communication Test and Measurement (CT&M) Market Worth $1.9 Billion by 2018 - New Report by MicroMarket Monitor 3Health News:North America Communication Test and Measurement (CT&M) Market Worth $1.9 Billion by 2018 - New Report by MicroMarket Monitor 4Health News:North America Communication Test and Measurement (CT&M) Market Worth $1.9 Billion by 2018 - New Report by MicroMarket Monitor 5Health News:Casinos in Australia Industry Market Research Report Now Updated by IBISWorld 2Health News:Casinos in Australia Industry Market Research Report Now Updated by IBISWorld 3Health News:Casinos in Australia Industry Market Research Report Now Updated by IBISWorld 4
... free site where consumers can both rate a hospital or ... ... Pasadena, CA (PRWEB) March 3, 2009 -- RateYourHospitalStay.com, http://www.rateyourhospitalstay.com , is ... across the U.S. The site also allows people who have recently ...
... releases the first in a series of residential vacuum cleaner reviews ... , ... Boise, Idaho (Vocus) March 3, 2009 -- Before spending hundreds of ... the market, savvy shoppers turn to the Internet to research their choices. ...
... Bausch & Lomb, the global eye health company, has ... Ltd., for the development of certain intraocular lens (IOL) ... Lomb has obtained the rights to Santen,s hydrophobic acrylic ... sale worldwide. Santen reserves the right for the use ...
... Moresby, Papua New Guinea The southeast Pacific ... the most biologically diverse ecosystems on Earth, has created ... swath of pristine tropical forest larger than Singapore. , ... in concert with local communities neighboring the newly established ...
... New studies in the United States and Canada show that ... of new mothers about infant crying, the most common trigger ... mothers in Seattle is featured in the March issue of ... Columbia appears this month in The Canadian Medical Association ...
... the U.S. Government Accountability Office (GAO) Report on the ... Responsible Nutrition (CRN), the leading trade association representing the ... from Steve Mister, president and CEO, CRN: "As ... that this one demonstrates that the industry has come ...
Cached Medicine News:Health News:Hospital Rating Site Launched, RateYourHospitalStay.com 2Health News:Hospital Rating Site Launched, RateYourHospitalStay.com 3Health News:Shopping for a Vacuum Cleaner? Know What You're Buying! Internet Site and Rating System Can Help 2Health News:Shopping for a Vacuum Cleaner? Know What You're Buying! Internet Site and Rating System Can Help 3Health News:Bausch & Lomb, Santen Strike Licensing Agreement for IOL Development 2Health News:Papua New Guinea declares first national conservation area 2Health News:Papua New Guinea declares first national conservation area 3Health News:Papua New Guinea declares first national conservation area 4Health News:New research shows program effective in educating parents about prevention of shaken baby syndrome 2Health News:CRN Responds to GAO Report on Dietary Supplements 2Health News:CRN Responds to GAO Report on Dietary Supplements 3
Lightweight, cordless lensmeter....
The quick access to diabetic screening, panoramic images of the retina including peripheral area are available by using easy, semi automatic guidance of peripheral fixation....
The LM-S1 manual lensmeter is particularly easy to use, since the adjustable viewing angle allows comfortable positioning. The high quality lensmeter operates on either AC power or batteries....
Non-mydriatic stereo fundus camera for glaucoma detection at early stage....
Medicine Products: